Mouthpiece
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
- Modified proteins and peptides
The broken lines in the drawings are included for the purpose of illustrating environment and form no part of the claimed design.
Claims
The ornamental design for a mouthpiece, as shown and described.
D412978 | August 17, 1999 | Cameron |
D433502 | November 7, 2000 | Rand |
D492771 | July 6, 2004 | King et al. |
D492994 | July 13, 2004 | King et al. |
D493222 | July 20, 2004 | King et al. |
D543273 | May 22, 2007 | Young et al. |
D560793 | January 29, 2008 | Pearl et al. |
D591856 | May 5, 2009 | Lulla et al. |
D596739 | July 21, 2009 | Ng et al. |
7726314 | June 1, 2010 | Ming |
000688023-0001 | May 2007 | EM |
000688023-0002 | May 2007 | EM |
000688023-0003 | May 2007 | EM |
000688023-0004 | May 2007 | EM |
000688023-0005 | May 2007 | EM |
000688023-0006 | May 2007 | EM |
000688023-0007 | May 2007 | EM |
000688023-0008 | May 2007 | EM |
000688023-0009 | May 2007 | EM |
000688023-0010 | May 2007 | EM |
000688023-0011 | May 2007 | EM |
000688023-0012 | May 2007 | EM |
000688023-0013 | May 2007 | EM |
000688023-0014 | May 2007 | EM |
000688023-0015 | May 2007 | EM |
000688023-0016 | May 2007 | EM |
000688023-0017 | May 2007 | EM |
000688023-0018 | May 2007 | EM |
000688023-0019 | May 2007 | EM |
000688023-0020 | May 2007 | EM |
000688023-0021 | May 2007 | EM |
000688023-0022 | May 2007 | EM |
000688023-0023 | May 2007 | EM |
000688023-0024 | May 2007 | EM |
000688023-0025 | May 2007 | EM |
000688023-0026 | May 2007 | EM |
000688023-0027 | May 2007 | EM |
000688023-0028 | May 2007 | EM |
D1296192 | March 2007 | JP |
D1296193 | March 2007 | JP |
3001971220000 | April 1997 | KR |
3003630260001 | September 2004 | KR |
433889 | February 1989 | TW |
500591 | December 2001 | TW |
495327 | November 2002 | TW |
495328 | November 2002 | TW |
D111283 | July 2004 | TW |
D122108 | September 2006 | TW |
2006097745 | September 2006 | WO |
2007028992 | March 2007 | WO |
2008023019 | February 2008 | WO |
- U.S. Appl. No. 29/277,858, filed Mar. 12, 2007.
- U.S. Appl. No. 12/377,412, filed Feb. 13, 2009.
Type: Grant
Filed: Aug 15, 2008
Date of Patent: Jun 19, 2012
Assignee: Glaxo Group Limited (Greenford Middlesex)
Inventors: Gregor John McLennan Anderson (Ware), Gary Thomas Crosby (Ware), Philip William Farr (Ware), Joseph Paul Marino (Ware), Mark Digby Teucher (Bristol), James Anthony West (Bristol)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles Hanson
Attorney: James P. Risk
Application Number: 29/322,977